EGFR and cancer: Several well-known abnormalities in signaling pathways contribute to the development and progression of this cancer, with the most common being the Wnt/β-catenin, P53, transforming growth factor-beta (TGF-beta) and epidermal growth factor receptor (EGFR) pathways [41].